Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

Université Laval

$69,254.00

Hormone-medicated improvement of recombinant protein yields in plants

FY 2016-17

Summary
The use of plants as bio-factories for the production of clinically useful recombinant proteins has been bolstered in recent years by the approval of a first plant-made biopharmaceutical for human therapy, the demonstrated feasibility of readily producing therapeutic antibodies in plants during the recent Ebola virus outbreak, and the ever increasing number of plant-made proteins undergoing Phase I or Phase II clinical trials. The goal of this project is to modulate the hormonal metabolism of Nicotiana benthamiana, a promising expression platform, in such a way as to boost recombinant protein yields while downregulating naturally abundant protein contaminants in leaves. Experiments will be conducted to evaluate the potential of exogenous hormone treatments, using a number of natural and synthetic chemicals applied in commercial production setups to control plant growth and development. Experiments will be conducted in parallel with hormone-inducing ""accessory transgenes"" to assess the feasibility of genetically reproducing the effects of chemical treatments. These new ways of enhancing recombinant protein yield in plants will be tested with different proteins of medical interest, including a regulatory protein used to control blood coagulation during cardiac surgeries, a model glycoprotein involved in immune and inflammatory diseases, and a viral antigen for the production of flu vaccines.
Program
Collaborative Research and Development Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
495852-2016
Name nom
Michaud, Dominique
Department département
Phytologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
69254
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
1
Nb partie
3
Application title
Hormone-medicated improvement of recombinant protein yields in plants
Keyword
NSERC
Application summary
The use of plants as bio-factories for the production of clinically useful recombinant proteins has been bolstered in recent years by the approval of a first plant-made biopharmaceutical for human therapy, the demonstrated feasibility of readily producing therapeutic antibodies in plants during the recent Ebola virus outbreak, and the ever increasing number of plant-made proteins undergoing Phase I or Phase II clinical trials. The goal of this project is to modulate the hormonal metabolism of Nicotiana benthamiana, a promising expression platform, in such a way as to boost recombinant protein yields while downregulating naturally abundant protein contaminants in leaves. Experiments will be conducted to evaluate the potential of exogenous hormone treatments, using a number of natural and synthetic chemicals applied in commercial production setups to control plant growth and development. Experiments will be conducted in parallel with hormone-inducing ""accessory transgenes"" to assess the feasibility of genetically reproducing the effects of chemical treatments. These new ways of enhancing recombinant protein yield in plants will be tested with different proteins of medical interest, including a regulatory protein used to control blood coagulation during cardiac surgeries, a model glycoprotein involved in immune and inflammatory diseases, and a viral antigen for the production of flu vaccines.